- Home
- CTOS vs NVAX Comparison
CTOS vs NVAX Comparison
Compare CTOS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOS
- NVAX
- Stock Information
- Founded
- CTOS 1988
- NVAX 1987
- Country
- CTOS United States
- NVAX United States
- Employees
- CTOS N/A
- NVAX N/A
- Industry
- CTOS Diversified Commercial Services
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTOS Consumer Discretionary
- NVAX Health Care
- Exchange
- CTOS Nasdaq
- NVAX Nasdaq
- Market Cap
- CTOS 1.4B
- NVAX 1.3B
- IPO Year
- CTOS N/A
- NVAX 1995
- Fundamental
- Price
- CTOS $5.69
- NVAX $8.18
- Analyst Decision
- CTOS Buy
- NVAX Buy
- Analyst Count
- CTOS 3
- NVAX 7
- Target Price
- CTOS $6.83
- NVAX $14.29
- AVG Volume (30 Days)
- CTOS 690.8K
- NVAX 7.2M
- Earning Date
- CTOS 10-29-2025
- NVAX 11-11-2025
- Dividend Yield
- CTOS N/A
- NVAX N/A
- EPS Growth
- CTOS N/A
- NVAX N/A
- EPS
- CTOS N/A
- NVAX 2.54
- Revenue
- CTOS $1,901,675,000.00
- NVAX $1,078,718,000.00
- Revenue This Year
- CTOS $13.58
- NVAX $61.69
- Revenue Next Year
- CTOS $5.18
- NVAX N/A
- P/E Ratio
- CTOS N/A
- NVAX $3.25
- Revenue Growth
- CTOS 6.21
- NVAX 9.22
- 52 Week Low
- CTOS $3.03
- NVAX $5.01
- 52 Week High
- CTOS $6.64
- NVAX $15.22
- Technical
- Relative Strength Index (RSI)
- CTOS 44.57
- NVAX 55.09
- Support Level
- CTOS $5.54
- NVAX $7.63
- Resistance Level
- CTOS $5.92
- NVAX $8.31
- Average True Range (ATR)
- CTOS 0.20
- NVAX 0.34
- MACD
- CTOS -0.06
- NVAX 0.01
- Stochastic Oscillator
- CTOS 18.59
- NVAX 88.89
About CTOS Custom Truck One Source Inc.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.